Study Protocol Evaluating Transient Tachypnoea of the Newborn in Term and Near Term Neonates
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Sep 13, 2005
Trial Information
Current as of June 26, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Neonate \> or = 34 weeks GA admitted in the first 6 hours of life with the suspected diagnosis of TTN (respiratory rate \> 60/mn, SpO2 \< 90% in room air, ilvermann score \> 0
- • Parental consent obtained
- Exclusion Criteria:
- • GA\> 42 weeks
- • meconial amniotic fluid
- • early onset neonatal sepsis (septic shock)
- • congenital malformations
- • enteral feeding started before admission
- • no parental consent
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
Patients applied
Trial Officials
Pierre KUHN, MD
Principal Investigator
Service de Pédiatrie, Hôpital de Hautepierre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials